Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo-Like Kinase 1 Interdomain Linker Affect Mitotic Behavior. [PDF]
Steyer C +5 more
europepmc +1 more source
Immunoinformatic-guided design of a polo-like kinase 1 (PLK1)-targeted multi-epitope vaccine with preliminary <i>in vitro</i> validation. [PDF]
Munieswaran G +3 more
europepmc +1 more source
Correction: Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling. [PDF]
Ou B +6 more
europepmc +1 more source
Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer. [PDF]
Parsyan A, Athwal H, Bhat V, Allan AL.
europepmc +1 more source
Polo-like kinase 4: A molecular linchpin in cancer and its management. [PDF]
Muntaqua D +3 more
europepmc +1 more source
Polo-like kinase Cdc5 orchestrates Cdk1 regulation via Swe1 and Mih1 during meiotic prophase I exit. [PDF]
González-Arranz S +5 more
europepmc +1 more source
Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study. [PDF]
Huang XJ +6 more
europepmc +1 more source
Functional and structural impacts of oncogenic missense variants on human polo-like kinase 1 protein. [PDF]
Munieswaran G, Manickam V.
europepmc +1 more source
Polo-Like Kinase 1 Phosphorylation Tunes the Functional Viscoelastic Properties of the Centrosome Scaffold. [PDF]
Amato M +5 more
europepmc +1 more source
A Mouse Model of Partial Pancreas Agenesis Induced by Polo-like kinase 1 Mutation. [PDF]
Chen X, Jia Z, Kuang S.
europepmc +1 more source

